Beyond ADHD: Treating Children with Co-occurring Conditions

48
Beyond ADHD: Treating Children with Co-occurring Conditions S. Steve Snow. MD Doug Emch MD Child Psychiatrists- Nashville, TN

description

Beyond ADHD: Treating Children with Co-occurring Conditions. S. Steve Snow. MD Doug Emch MD Child Psychiatrists- Nashville, TN. Professional Affiliations. Private Practice, Child/Adolescent/Adult Psychiatry. Belle Meade Office Park, 4535 Harding RD Nashville TN 37205 (Emch and Snow). - PowerPoint PPT Presentation

Transcript of Beyond ADHD: Treating Children with Co-occurring Conditions

Page 1: Beyond ADHD: Treating Children with Co-occurring Conditions

Beyond ADHD:Treating Children with Co-occurring Conditions

S. Steve Snow. MDDoug Emch MD

Child Psychiatrists- Nashville, TN

Page 2: Beyond ADHD: Treating Children with Co-occurring Conditions

Professional Affiliations• Private Practice, Child/Adolescent/Adult Psychiatry.

Belle Meade Office Park, 4535 Harding RDNashville TN 37205 (Emch and Snow).

• Clinical Professor of Psychiatry, Vanderbilt University (Snow)• Child/Adolescent Psychiatrist, Centerstone Mental Health

Centers (Emch)• Child/Adolescent Psychiatrist, Namaste, Inc. (Emch) • Child Adolescent Psychiatrist, Teambuilders Counseling Services,

Inc. (Emch)

Page 3: Beyond ADHD: Treating Children with Co-occurring Conditions

Disclosures

• Speaker’s Bureaus: Eli Lilly and Novartis Pharmaceutical Companies (Snow)

• Preparation of the presentation received no commercial support

• Off-label uses of medications, such as lack of approval for specific diagnosis or certain ages, as frequently used by psychiatrists, will be included.

Page 4: Beyond ADHD: Treating Children with Co-occurring Conditions

Learning Objectives

• Review diagnostic guidelines for Attention Deficit Hyperactivity Disorders (DSM-IV-TR)

• Identify common co-occurring conditions with ADHD, and disorders which mimic ADHD

• Update pharmacotherapy for ADHD and it’s co-occurring disorders

Page 5: Beyond ADHD: Treating Children with Co-occurring Conditions

Presentation Outline

• ADHD• Mimicry• Comorbid Conditions• Pharmacotherapy• Questions?

Page 6: Beyond ADHD: Treating Children with Co-occurring Conditions

ADHDInattention • Careless

• Inattentive• Not listening• Poor

instructions

• Disorganized• Avoids• Loses things• Distracted• Forgetful

Hyperactivity

Impulsivity

• Fidgets• Out of seat• Climbs/runs

• Loud• On the go• Talkative

• Blurts out• Impatient• Interrupts

Page 7: Beyond ADHD: Treating Children with Co-occurring Conditions

ADHD Subtypes

• Predominantly Inattentive (20-30%)• Predominantly Hyperactive/Impulsive (<15%)• Combined hyperactive-impulsive and

inattentive (50-75%)

Page 8: Beyond ADHD: Treating Children with Co-occurring Conditions

Etiology

• Genetic– Heritability about 76%– Complex - Chromosomes 4,5,6,8,11,16,17

• Non-Genetic– Perinatal stress and low birth-weight– Traumatic brain injury– In utero substance exposure– Trauma– Society?

Farone, Molecular Genetics of ADHD, Biol Psychiatry 57:1313-1323 (2005)

Page 9: Beyond ADHD: Treating Children with Co-occurring Conditions

…in accordance with the ADHDTV standard, that all shows be no more than six minutes in length, and that they contain jarring and unpredictable camera cuts to shiny props and detailed background sets…

QuickTime™ and a decompressor

are needed to see this picture.

FCC: All Programming To Be Broadcast in ADHDTV by 2007

QuickTime™ and a decompressor

are needed to see this picture.

Page 10: Beyond ADHD: Treating Children with Co-occurring Conditions

Prevalence

• 1-20% of child/adolescent population (5-8%)• Account for 30-50% of child referrals to

mental health services• 4-5% of adult population• Males:Females :: 9:1 4:1 2:1

Page 11: Beyond ADHD: Treating Children with Co-occurring Conditions

Mimicry• Learning disorders• Hypoglycemia/Diabetes• Hypo/hyperthyroidism• Allergies • Hearing/vision problems• Toxicity (lead, mercury)• Epilepsy• Nutrient deficiencies • Anemia• Sensory integration

dysfunction

• Anxiety disorders• Bipolar/depression• Trauma/PTSD• Attachment disorders• Sleep disorders• Infections• Pain• Traumatic Brain Injuries• Fetal Alcohol Syndrome• Substance abuse• Family problems

Page 12: Beyond ADHD: Treating Children with Co-occurring Conditions

Comorbidity

• Almost 3/4’s of individuals with ADHD have a psychiatric comorbidity:– Conduct Disorder (10-20%)– ODD (54-84%)– Substance Abuse (40%)– Anxiety Disorders (30-40%)– Affective Disorders (20-30%)– Learning Disorders (@ 33-60%)– Tic Disorders (34%) – Developmental Disorders (?)– Sleep disorders (25-50%)

Page 13: Beyond ADHD: Treating Children with Co-occurring Conditions

Academic Impairment

• Very well documented– Failure to perform academically is the single most common source of

referral for children and adolescents

• Children with ADHD– Perform poorly on achievement tests and fail grades / courses

significantly more often than children without ADHD– Complete 3 fewer years of education than matched controls– More likely not to graduate from high school (35%)

• Academic impairment more profound when learning disabilities are present

Weiss & Hechtman Hyperactive Children Grown Up 1993Manuzza & Klein The Economics of Neuroscience, 2001:47-53

Page 14: Beyond ADHD: Treating Children with Co-occurring Conditions

Social Function

• Social problems begin in childhood, persist into adolescence– Fewer friends, more limited social skills– Lower self esteem on assessment scores– 3X’s as likely to have trouble getting along with peers– ½ as likely to have good friends– 2Xs as likely to get picked on by peers– 3Xs as likely to have problems that limit after school

activities

Suppl. JAACAP Practice Parameters for Use of Stimulant Medications 2002;41:26S-49SI.M.P.A.C.T. Survey;NYU Child Study Center;2001

Page 15: Beyond ADHD: Treating Children with Co-occurring Conditions

Sexual Behaviors

• Longitudinal follow-up of cohort of 160 children with ADHD shows:– More unprotected sex & >50% tested for HIV

• 0 in the control group

– Of 43 children born to study participants, 42 were born to those in the ADHD group

• Limiting their academic and occupational attainment• 54% of these had lost custody of the children

Barkley. Attention 1996;8-11

Page 16: Beyond ADHD: Treating Children with Co-occurring Conditions

Criminality

• ADHD has high comorbidity with ODD and CD– Coupled with an impulsive, high risk lifestyle

• increases risk for legal problems

• Patients with ADHD more likely to be:– Arrested (39% vs. 20%)– Convicted (28% vs. 11%)– Jailed (9% vs. 1%)

Biederman et. al. Arch Gen Psychiatry 1996;53,437Manuzza et. al. Arch Gen Psychiatry 1989;46,1073

Page 17: Beyond ADHD: Treating Children with Co-occurring Conditions

Oppositional Defiant DisorderODD

• Pattern of negative/hostile/defiant behavior – Loses temper– Argues with adults– Defies adults’ requests/rules– Deliberately annoys others– Blames others– Touchy/annoyed easily– Angry/resentful– Spiteful/vindictive

Page 18: Beyond ADHD: Treating Children with Co-occurring Conditions

Conduct Disorder

• Aggression to people and animals• Destruction of Property• Deceitfulness, lying, stealing• Serious violation of rules

Page 19: Beyond ADHD: Treating Children with Co-occurring Conditions

TICs

• Transient Tic• Chronic Motor or Vocal Tic• Tourette’s (Motor and Vocal)

Page 20: Beyond ADHD: Treating Children with Co-occurring Conditions

Sleep Requirementsper 24 hours

• Infant to 6 months: 16-20 hours

• 6mo to 2 yrs: roughly 15 hours

• 2 to 6 yrs: 10-12 hours

• Grade School (7 to 13 yrs): 9 to 11 hours

• High School (14 to 18 yrs): roughly 9 to 10 hours (may vary greatly day by day)

Dr. Scott Shannon Please Don’t Label My Child

Page 21: Beyond ADHD: Treating Children with Co-occurring Conditions

Anxiety Disorders

• Generalized• Separation• Obsessive-Compulsive• Specific & Social Phobia• Panic• Stress Disorders/PTSD

Page 22: Beyond ADHD: Treating Children with Co-occurring Conditions

Affective Disorders

• Depression• Dysthymia• Cyclothymia• Bipolar

Page 23: Beyond ADHD: Treating Children with Co-occurring Conditions

Depression

• Prevalence– 2% Children– 4-8% Adolescents– Male:female 1:1 1:2– 20% cumulative incidence by 18– 5-10% children/adolescents subsyndromal

JAACAP Practice Parameter 46:11, Nov 2007

Page 24: Beyond ADHD: Treating Children with Co-occurring Conditions

Depression

• 2 weeks of (5):– Depressed mood or irritability, or– Loss of interest/pleasure– Wt change (failure to thrive)– Sleep changes– Psychomotor agitation/retardation– Fatigue– Feeling worthless/guilty– Poor concentration/indecisiveness– Recurrent thoughts of death or suicide

Page 25: Beyond ADHD: Treating Children with Co-occurring Conditions

Dysthymia

• Depressed mood or irritability on most days for most of the day for 1 year

• Plus– Changes in appetite or weight– Changes in Sleep– Problems with decision making or concentration– Low self-esteem, energy, hope

Page 26: Beyond ADHD: Treating Children with Co-occurring Conditions

Juvenile Bipolar Disorder• Adult criteria in DSM; none for youngsters• Severe type of mood disorder; manic-depressive illness• Episodes of mania, major depression, or both, often with

psychosis• Mania includes hyperactivity, which can mimic ADHD, but

also elation, grandiosity, and flight of ideas; may not sleep for days

• Irritability and rapid speech seen with both• Depression often very severe, sometimes mixed with

mania; can be suicidal, psychotic, even look catatonic• Key is an up and down course, with children and teens

often cycling very rapidly, unlike most adults

Page 27: Beyond ADHD: Treating Children with Co-occurring Conditions

Developmental Problems and Substance Abuse

• Many types of underlying developmental disorder, as well as external factors such as illicit substance use, and complicate or mimic ADHD

• Autistic Spectrum Disorder overrides and presumably includes ADHD, under current DSM guidelines, although frequently ADHD sx are marked in these pts and the target of Tx

• Cocaine, methamphetamine and other stimulant abuse can mimic ADHD sx, but even marijuana and other CNS-depressant substances can result in dreamy, off-task school performance

Page 28: Beyond ADHD: Treating Children with Co-occurring Conditions

Developmental Disorders• Co-occurring developmental disorders are the rule with

ADHD, but may not be medication targets and require specialized learning approaches:

• Mental Retardation, of varying degrees of severity, may be changed to Intellectual Disability or similar term in DSM-V.

• Learning Disorder include Reading, Math and Written Language disabilities

• Developmental Coordination Disorder may produce problems in sports, predispose to minor injuries, but also be a target of teasing or hazing

Page 29: Beyond ADHD: Treating Children with Co-occurring Conditions

Developmental Disorders (cont)• Communication Disorders include both expressive and receptive language

disabilities, as well as Phonological (Articulation) disorders and Stuttering

• Elimination Disorders include enuresis or encopresis and may require both medical and behavioral intervention

• Tic Disorder are specified as transient, chronic motor or vocal and Tourette’s Syndrome; most individuals with Tourette’s have parallel ADHD sx and often OCD, as well; stimulants may exacerbate tics and RX may be complex

• Haloperidol (Haldol) and pimozide (Orap) are problematic older drugs, age 12 and older for pimoxide, but atypical agents as will be discussed for bipolar disorders are used off-label for severe T.S.

Page 30: Beyond ADHD: Treating Children with Co-occurring Conditions

Treatment

QuickTime™ and a decompressor

are needed to see this picture.

Page 31: Beyond ADHD: Treating Children with Co-occurring Conditions

Medications for ADHD

• Stimulants – methylphenidates, amphetamines

• Alpha-agonists– Clonidine, Tenex, Intuniv, Kapvay

• NE/DA Active Antidepressants – Wellbutrin

• Strattera• Provigil/Nuvigil• Tricyclic Antidepressants

Page 32: Beyond ADHD: Treating Children with Co-occurring Conditions

Duration of Action

• 2-5 hours• methylphenidate (MPH) (Ritalin) (1-4 hrs)• d-MPH (Focalin) (1-4 hrs)• d-amphetamine (Dexedrine) (1-6 hrs)• Amphetamine-dextroamphetamine (Adderall) (4-6hrs)

• 5-8 hours• methylphenidate SR (Ritalin SR) (3-8 hrs)• methylphenidate ER (Metadate ER, Methylin ER) (3-8 hrs)• d-amphetamine (Dexedrine Spansules) (6-8 hrs)• extended release MPH (Ritalin LA & Metadate CD) (6-8 hrs)

• 10-12 hours• methylphenidate (Concerta) (10-12 hrs)• dexmethylphenidate (Focalin XR) (10-12hrs)• Methylphenidate transdermal (Daytrana) (9-12)• amphetamine-dextroamphetamine (Adderall XR) (10-12 hrs)• lisdexamfetamine (Vyvanse)- (12-14hrs)

Page 33: Beyond ADHD: Treating Children with Co-occurring Conditions

Stimulant Side Effects

• Delay of sleep onset• Reduced appetite• Weight loss• Tics• Stomach ache• Headache• Jitteriness

But not necessarily• Staring• Daydreaming• Irritability• Anxiety• Nail biting

Suppl. JAACAP Practice Parameters for Use of Stimulant Medications 2002;41,#2:29S

Page 34: Beyond ADHD: Treating Children with Co-occurring Conditions

Diet

• Issues with sugars and dyes• Citric Acid and Ascorbic Acid

– Citrus fruits, juices– Coke, Diet Coke, Dr. Pepper, A&W Root Beer

• Not the clear, yellow, or red drinks

– Cereals, MVI– Anything in foil wrappers

• High fat diets

Page 35: Beyond ADHD: Treating Children with Co-occurring Conditions

Medications for ADHD

• Stimulants– methylphenidates, amphetamines

• Alpha-agonists– Clonidine, Tenex, Intuniv, Kapvay

• NE/DA Active Antidepressants– Wellbutrin

• Strattera• Provigil/Nuvigil• Tricyclic Antidepressants

Page 36: Beyond ADHD: Treating Children with Co-occurring Conditions

Antidepresants

• SSRIs– Fluxoetine (Prozac), Sertraline (Zoloft), Citalopram

(Celexa), Escitalopram (Lexapro), Paroxetine (Paxil), Fluvoxamine (Luvox)

• SNRIs– Venlafaxine (Effexor), Desvenlafaxine (Pristiq), Duloxetine

(Cymbalta)

• NE/DA– Buproprion (Wellbutrin)

Page 37: Beyond ADHD: Treating Children with Co-occurring Conditions

Antidepressants (cont)

• Tricyclics– Imipramine (Tofranil), Amitriptyline (Elavil),

Clomipramine (Anafranil)

• Other– Trazodone, Remeron

Page 38: Beyond ADHD: Treating Children with Co-occurring Conditions

SSRI Side Effects

• Common– sleep changes – restlessness – headaches – akathisia– appetite changes – sexual dysfunction

• 3-8% youths– impulsivity– agitation– irritability– silliness– “behavioral

activation”

Black Box Warning: Suicidality

JAACAP Practice Parameter 46:11, Nov 2007

Page 39: Beyond ADHD: Treating Children with Co-occurring Conditions

Anxiolytics

• SSRIs– Prozac, Zoloft, Celexa

• Buspar• Neurontin• Strattera?• Benzodiazepines

– Valium, Klonopin, Ativan

Page 40: Beyond ADHD: Treating Children with Co-occurring Conditions

Pharmacotherapy of Bipolar Disorder

• Lithium carbonate, typically from 150 mg to 450mg, one to two tabs or caps, up to BID often in controlled-release form

• FDA approval ages 12-17; many side effects, including tremor, thirst and somnolence; lab needed to monitor Li levels, electrolytes, renal and thyroid studies

• Calms mania and helps prevent mood excursions, but not very effective for depression

• Less likely now to be the first agent prescribed

Page 41: Beyond ADHD: Treating Children with Co-occurring Conditions

Bipolar Treatment:Anticonvulsants

• Anticonvulsant “mood stabilizers”• Commonly prescribed, approvals for pediatric epilepsy, but

not for mood problems• Valproic Acid (Depakote) has adult bipolar indication; dose

range 125mg BID to as much as 750mg BID, or more; may cause drowsiness or ataxia; lab monitoring for serious liver, pancreatic or heme A.E.’s

• Lamotrigine (Lamictal) also has adult bipolar indication; dose range 25mg BID to 150mg BID, or more; usually well-tolerated and no blood monitoring, but rare toxic rashes, and very slow acclimation

Page 42: Beyond ADHD: Treating Children with Co-occurring Conditions

Anticonvulsants (cont)• Oxcarbamazepine (Trileptal) does not have an indication for mood

disorders, adult or children, but has had considerable clinical use, and largely replaced carbamazepine (Tegetol); usually tolerated except for sedation and hyponatremia, though not usually a problem; dosed 150mg BID up to 600mg BID or more

• Topiramate (Topamax) also used off label in doses of 50-100mg BID, up to 200mg BID or more, but may cause some cognitive difficulties, such as anomia, and predispose to renal stone formation

• Gabapentine (Neurontin) used off label in doses of 100mg BID or TID, to as much as 600mg TID or more; some initial fatigue, like other agents, but generally well-tolerated and does not interact much with other drugs

Page 43: Beyond ADHD: Treating Children with Co-occurring Conditions

Bipolar Treatment:Atypicals

• Atypical neuroleptics, such as Risperidone, Aripiprazole, and Olanzepine have mostly replaced older agents, such as Haloperidol and Thioridazine, so-called “typical neuroleptics”

• Risperidone (Risperdal) in doses from 0.25mg BID, all the way to 4mg BID, or more, treat mania and stabilize bipolar episodes; approved in children and adolescents ages 10 and up for mania; can cause significant weight gain, sedation, prolactin stimulation and other adverse effects

• Aripiprazole (Abilify) approved ages 10-17 and used in doses of 2mg daily up to a maximum of 30mg per day, often in divided doses; generally not as much weight increase, but may cause restlessness and dystonias; does not elevate prolactin

Page 44: Beyond ADHD: Treating Children with Co-occurring Conditions

Atypical Antipsychotics (cont)

• Olanzepine (Zyprexa) is a potent anti-psychotic, with concerns of weight gain and subsequent metabolic problems, but does have an approval for bipolar 1 disorder, ages 13-17; dose ranges from 2.5 to 30mg, or more

• Quiatepine (Seroquel) is not approved in children or adolescents, but used for insomnia of bipolar disorders, and for psychosis and mood stability in higher doses, range from 25 to 800mg or more, off label. Sedation and wt gain as S.E.’s

• Ziprasidone (Geodon), also non-approved in kids, but sometimes used because of wt. gain from other agents, or sedation from other agents; more concern in children of QT prolongation on EKG; more EPS and akathisia; does not raise prolactin levels

Page 45: Beyond ADHD: Treating Children with Co-occurring Conditions

Parent Medication Guide

• Newly revised guide for Depression in children and adolescents

• Comprehensive guide to ADHD Rx; nice discussion of conditions that accompany and/or “show the same type of sx”

• Joint project of American Psychiatric Association and American Academy of Child and Adolescent Psychiatry

• Available at ParentsMedGuide.org• Slides available at www.emchpsychiatry.com

Page 46: Beyond ADHD: Treating Children with Co-occurring Conditions

?

Page 47: Beyond ADHD: Treating Children with Co-occurring Conditions

• Enhances signal• Improves attention

– Focus– Vigilance– Acquisition– On-task behavior– On-task cognition

Solanto. Stimulant Drugs and ADHD. Oxford; 2001.

Nigrostriatal Pathway

Ventral tegmental area

DopamineDopamine

Mesocortical Pathway

Mesolimbic Pathway

Substantia nigra

Page 48: Beyond ADHD: Treating Children with Co-occurring Conditions

Solanto. Stimulant Drugs and ADHD. Oxford; 2001.

NorepinephrineNorepinephrine

Frontal

Limbic

Locus ceruleus

• Dampens noise• Decreases shifting• Executive operations• Increases inhibition

–Behavioral–Cognitive–Motoric